Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Good post Greekman, now this thread finally has some substance which is related to the market position. Its not about the savings or op time frames as we know, these have already been proven. Just one look at the NHS tells us that money is its primary concern right now. That position isn't however that of the market and Deltex should be pushing the private sector hard rather than winging about the NHS which isn't in the position to offer anything.

Sad but true, if the NHS was privitised then all Deltex holders would be laughing!!

If anyone saw the pro gramme last night re the NHS, (Can Gerry Robinson fix the NHS) it clearly showed when they visited the money holders (the trust finance mongers) that they did not want more patients treated as this would multiply the cost and put said trust even deeper in the red.
It also clearly showed what we all know, someone has a good idea, they then have a meeting (eventually), and then sit on any decision for months, sometimes years or as long as it takes to go away. No one is a decisive decision maker. The Exec was surprised to learn that if he got out among those that do the graft, ie on ground level they, the patients and he would benefit. Not exactly brain storming thinking, and this Exec must be very well paid. Gerry Robinson found out within a short period how to save money and time by talking to those who do the actual job from cleaners to consultants. Most of the suggestion were obviously. My wife who is a Nurse was continually commenting, " We have been saying this for years, and the management never listen". But this was a surprise to the Exec. Says it all really.

Re the RNS,

Excellent news.
Can't see these trials being anything less successful as all the others that have gone before it.
Lets just hope that this will move that proverbial stone that has been stuck on the slope of the cant/don't spend syndrome.

Look for increased institutional buying, and the very good possibility of sales in similar circumstances in the USA. Baby business in the US is big.

Deltex Medical Group plc First sales of SupraQTM and CardioQTM monitors into maternity units That's the news I like to read.. I have been following the story at www.shareclubuk.co.uk the above news will help with more sales which in turn lead to profits.. I agree greekman the US market could be very big for DEMG.

The trading update looks very good, mainly for future sales.
The only annoying mention was that NICE are and have been lagging behind compared to other such organizations world wide.
It re iterates that the NHS crawl along whilst others take the lead. (Mismanagement once again)
Well done DELTEX. This now looks excellent for the future as the CardioQ does not appear to have any competition.

Yes very good update, as always we requires more sales. Anyone looking at the total buys/sells will get a wrong impression, there are 135,000 shares down as sells when infact they are buys, I know I've mentioned it before but it does give a distorted picture of trading in shares. (Bee in my bonnet atm)
2517

Good contract win.
2517

Yes,excellent news. The involvment by the USA in Iraq could be a good in making other none military establishments take note. Can't understand why the sp is static.

The sp is just not budging.
2517

In my opinion lethargy rules re this share. There have been so many similar announcement re very small sales that the market has become immune to such details overlooking the bigger picture ( I know thats a saying that politicians overuse ) but that bigger picture looks excellent. When the market does wake up, that to me is when the Sp will relay take off.
The involvement by the USA in Iraq could be a good in making other none military establishments take note. To me the RNS is good news especially for the future.

I see the FD purchased 150k shares and the CE a more modest 6k+ shares on friday, always nice to see, especially when it's the FD of a co.
2517

Hi George,

Just seen it. Always good to see directors buying into their companies.

Maybe the message is beginning to get around, topped up modestly yesterday.
2517

The sp is right on the 200dma so a push through that should be positive.
2517

Not one buy so far today, sp unmoved atm, perhaps there's a large buyer sitting in the wings ready to mop up.
2517

Upbeat mention in shares today.
2517

Yet another contract. It's not the tiny number of CardioQ's thats important, its the foot in the door of yet another hospital.
Also teaching hospitals are ideal for spreading the word, via those going out into the medical world.
This share is like a bolder stuck on a hill, very hard to move, but once it starts to roll, try stopping it.

greekman do you know how many probes are used per operation, I recollect each probe costs 60 to the end user, so how much profit per probe for DEMG any ideas. Thanks
2517

Hi George,

According to Deltex Corporate ( spoke to a very helpful lady ) it's 1 per operation.

She also informed me there are 3 different probes.

A 6 hour probe for short operations.
A 12 hour probe for longer ops.
A 10 day probe for ICU.

From the latest NHS figures, they carry out 7 million operations per year, so with ICU probes the profit per year could be substantial and thats just probes for the NHS.
So with the whole world as there potential customer, the profit from monitors and probes looks nice and juicy.

As a foot note.

I contact several companies per year re my shares and can say that very few are as forthcoming and as helpful as the lady I spoke to.

Thanks greekman, according to shares mag yesterday there are in excess of 1250 Cardio Q units in use in hospitals worldwide, and I just wondered how many probes were used because they generate profit for the co. Like you say the potential is substantial, and small contract wins such as Iraq and Berlin recently all help to spread the word. I contacted Andy Hill last year and was impressed myself, so I think the co does it's best to keep investors informed.
2517